Pieters R - Search Results

1

Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol.

Stutterheim J, van der Sluis IM, de Lorenzo P, Alten J, Ancliffe P, Attarbaschi A, Brethon B, Biondi A, Campbell M, Cazzaniga G, Escherich G, Ferster A, Kotecha RS, Lausen B, Li CK, Lo Nigro L, Locatelli F, Marschalek R, Meyer C, Schrappe M, Stary J, Vora A, Zuna J, van der Velden VHJ, Szczepanski T, Valsecchi MG, Pieters R. Stutterheim J, et al. Among authors: pieters r. J Clin Oncol. 2021 Feb 20;39(6):652-662. doi: 10.1200/JCO.20.02333. Epub 2021 Jan 6. J Clin Oncol. 2021. PMID: 33405950 Free PMC article.

2

Value of routine bone marrow examination for detection of bone marrow relapse in children with standard risk acute lymphoblastic leukemia.

Haumann TJ, van Wering ER, van der Does-van den Berg A, Pieters R, Huisjes AJ, Veerman AJ. Haumann TJ, et al. Among authors: pieters r. Pediatr Hematol Oncol. 1992 Jan-Mar;9(1):41-7. doi: 10.3109/08880019209006395. Pediatr Hematol Oncol. 1992. PMID: 1558775

3

Clinical relevance of in vitro drug resistance testing in childhood acute lymphoblastic leukemia: the state of the art.

Pieters R, Kaspers GJ, Klumper E, Veerman AJ. Pieters R, et al. Med Pediatr Oncol. 1994;22(5):299-308. doi: 10.1002/mpo.2950220502. Med Pediatr Oncol. 1994. PMID: 8127253

4

Everything you always wanted to know about cellular drug resistance in childhood acute lymphoblastic leukemia.

Pieters R, Klumper E, Kaspers GJ, Veerman AJ. Pieters R, et al. Crit Rev Oncol Hematol. 1997 Jan;25(1):11-26. doi: 10.1016/s1040-8428(96)00223-5. Crit Rev Oncol Hematol. 1997. PMID: 9134309 Review. No abstract available.

5

Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants.

Pieters R, den Boer ML, Durian M, Janka G, Schmiegelow K, Kaspers GJ, van Wering ER, Veerman AJ. Pieters R, et al. Leukemia. 1998 Sep;12(9):1344-8. doi: 10.1038/sj.leu.2401129. Leukemia. 1998. PMID: 9737681

6

Biological and therapeutic aspects of infant leukemia.

Biondi A, Cimino G, Pieters R, Pui CH. Biondi A, et al. Among authors: pieters r. Blood. 2000 Jul 1;96(1):24-33. Blood. 2000. PMID: 10891426 Free article. Review. No abstract available.

7

Post-induction residual leukemia in childhood acute lymphoblastic leukemia quantified by PCR correlates with in vitro prednisolone resistance.

Schmiegelow K, Nyvold C, Seyfarth J, Pieters R, Rottier MM, Knabe N, Ryder LP, Madsen HO, Svejgaard A, Kaspers GJ. Schmiegelow K, et al. Among authors: pieters r. Leukemia. 2001 Jul;15(7):1066-71. doi: 10.1038/sj.leu.2402144. Leukemia. 2001. PMID: 11455975

8

Is there a relationship between in vitro drug resistance and level of minimal residual disease as detected by polymerase chain reaction at the end of induction therapy in childhood acute lymphoblastic leukaemia?

De Haas V, Kaspers GJ, Oosten L, Bresters D, Pieters R, Van Der Velden VH, Van Wering ER, Van Den Berg H, Van Der Schoot CE. De Haas V, et al. Among authors: pieters r. Br J Haematol. 2002 Sep;118(4):1190-1. doi: 10.1046/j.1365-2141.2002.36211.x. Br J Haematol. 2002. PMID: 12199807 Free article. No abstract available.

9

Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia.

Stam RW, den Boer ML, Meijerink JP, Ebus ME, Peters GJ, Noordhuis P, Janka-Schaub GE, Armstrong SA, Korsmeyer SJ, Pieters R. Stam RW, et al. Among authors: pieters r. Blood. 2003 Feb 15;101(4):1270-6. doi: 10.1182/blood-2002-05-1600. Epub 2002 Oct 24. Blood. 2003. PMID: 12406912 Free article.

10

Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.

Den Boer ML, Harms DO, Pieters R, Kazemier KM, Gobel U, Körholz D, Graubner U, Haas RJ, Jorch N, Spaar HJ, Kaspers GJ, Kamps WA, Van der Does-Van den Berg A, Van Wering ER, Veerman AJ, Janka-Schaub GE. Den Boer ML, et al. Among authors: pieters r. J Clin Oncol. 2003 Sep 1;21(17):3262-8. doi: 10.1200/JCO.2003.11.031. J Clin Oncol. 2003. PMID: 12947061

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

997 results

Search Page